Copyright: ©Author(s) 2026.
World J Gastrointest Oncol. May 15, 2026; 18(5): 117580
Published online May 15, 2026. doi: 10.4251/wjgo.v18.i5.117580
Published online May 15, 2026. doi: 10.4251/wjgo.v18.i5.117580
Figure 1 Study protocol.
GAC: Gastric adenocarcinoma; OS: Overall survival; PGASC: Primary gastric adenosquamous carcinoma; PSM: Propensity score matching.
Figure 2 Overall survival in patients with gastric adenocarcinoma and primary gastric adenosquamous carcinoma.
GAC: Gastric adenocarcinoma; PGASC: Primary gastric adenosquamous carcinoma.
Figure 3 Overall survival between patients with and without chemotherapy in the locally advanced gastric adenocarcinoma and the locally advanced primary gastric adenosquamous carcinoma groups.
A: The gastric adenocarcinoma group after propensity score matching. Patients receiving adjuvant chemotherapy (blue line, n = 52) showed significantly better survival than those without (red line, n = 10) (log-rank test, P < 0.010); B: The primary gastric adenosquamous carcinoma group after propensity score matching. No significant difference was observed between the chemotherapy (blue line, n = 33) and non-chemotherapy (red line, n = 29) subgroups (time-dependent Cox regression, P = 0.810).
- Citation: Chen YW, Dong ZY, Wang XX, Cao Y, Lin JX, Chen H, Zhang HY, Xiao YB, Li GX, Li ZR, Chen L, Xia X, Zhang ZZ. Characteristics and prognosis of primary gastric adenosquamous carcinoma: A multicenter retrospective study based on propensity score matching. World J Gastrointest Oncol 2026; 18(5): 117580
- URL: https://www.wjgnet.com/1948-5204/full/v18/i5/117580.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v18.i5.117580